Hirose et al. showed that temozolomide (TMZ) treatment of glioma cell lines in vitro leads to CDC2 phosphorylation at Tyr15, and that inhibition of cell cycle progression by pTyr15CDC2 may be an important step in TMZ-induced cytotoxicity [20]. Here, CDK1 is linked to central nervous system cancer.